← Eichor
Condition: Cervical Intraepithelial Neoplasia Grade 2 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cervical Intraepithelial Neoplasia Grade 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Digital Telecytology for Triage of HPV-Positive Women in Cameroon
NA · 2 location(s) · University Hospital, Geneva · NCT07550010Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396Evaluation of the PreCursor-M+® in CIN2
Phase N/A · 2 location(s) · European Institute of Oncology · NCT06403618HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical I
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT04057924Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Phase N/A · 1 location(s) · University of Pretoria · NCT02956031Regression of Cervical Precancerous Lesions and Associated Risk Factors
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT06147388Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Phase 4 · 1 location(s) · Miriam Elfström · NCT04910802A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Phase 2 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06210854Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05413798Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Phase N/A · 20 location(s) · Fujian Maternity and Child Health Hospital · NCT05282095Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05027776Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Phase 2 · 7 location(s) · Frantz Viral Therapeutics, LLC · NCT04098744Effect of Honey For CIN II
Phase 1/Phase 2 · 2 location(s) · Zuyderland Medisch Centrum · NCT06219018A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
NA · 1 location(s) · Papillex Inc. · NCT06979180
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.